Brief: Oncolytics Biotech qtrly loss per share $0.02
Nov 5 (Reuters) - Oncolytics Biotech Inc ONC.TO : * Biotech inc. announces 2015 third quarter results * Qtrly loss per share $0.02 * Source text for Eikon ID:nCNW409B6a * Further company coverage ONC.TO ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Announces Clinical Supply Agreement To Evaluate Pelareorep In Combination With Loqtorzi In Squamous Cell Anal Carcinoma
Brief: Oncolytics Says Pelareorep Shows Durable Survival Benefit in Anal Cancer
Brief: Oncolytics Biotech Expects Final Cohort 4 Results Of Goblet Study In Q4 2026
Brief: Oncolytics Biotech® Secures Patent Protection To Late 2040S And Provides Intellectual Property Portfolio Update
Brief: Oncolytics Biotech® Aligns With FDA On Registrational Path For Second-Line Ras-Mutant Mss Colorectal Cancer